A QUICKSCORE METHOD FOR IMMUNOHISTOCHEMICAL SEMIQUANTITATION - VALIDATION FOR ESTROGEN-RECEPTOR IN BREAST CARCINOMAS

被引:709
作者
DETRE, S [1 ]
JOTTI, GS [1 ]
DOWSETT, M [1 ]
机构
[1] UNIV PARMA,IST ANAT & ISTOL PATOL,PARMA,ITALY
关键词
IMMUNOHISTOCHEMISTRY; QUICKSCORE; ESTROGEN RECEPTOR; BREAST CANCER;
D O I
10.1136/jcp.48.9.876
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Immunohistochemistry is increasingly used in the assessment of markers for breast cancer prognosis. Semiquantitation is frequently desirable but, other than by the use of image analysis, the approaches currently in use are cumbersome. Tire most common method used is the H-score which takes into consideration the staining intensity in conjunction with the percentage of cells staining positively in breast carcinoma tissue, A ''quickscore'' has been developed which dispenses with the need to count individual cells. The quantitative biochemical Abbott enzyme immunoassay (EIA) and the Dako immunohistochemical assay (IHA) incorporating a semiquantitative H-score, have been used as standards against which the MA quickscore for the semiquantitation of oestrogen receptor expression was tested. A good correlation was found between the quickscore and the EIA, which was as good as that between the H-score and EIA. The quickscore is a valid approach and there is no advantage in using the more rigorous H-score, A positive cut off quickscore of greater than or equal to 3 has been suggested.
引用
收藏
页码:876 / 878
页数:3
相关论文
共 7 条
[1]   RELATIONSHIP BETWEEN RADIOLIGAND BINDING ASSAY, IMMUNOENZYME ASSAY AND IMMUNOHISTOCHEMICAL ASSAY FOR ESTROGEN-RECEPTORS IN HUMAN-BREAST CANCER AND ASSOCIATION WITH TUMOR DIFFERENTIATION [J].
ANDERSEN, J ;
BENTZEN, SM ;
POULSEN, HS .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (03) :377-384
[2]   DETERMINATION OF ESTROGEN-RECEPTORS IN PARAFFIN-EMBEDDED TISSUE - TECHNIQUES AND THE VALUE IN BREAST-CANCER-TREATMENT [J].
ANDERSEN, J .
ACTA ONCOLOGICA, 1992, 31 (06) :611-627
[3]   IMMUNOHISTOCHEMICAL DETECTION OF P53 PROTEIN IN MAMMARY-CARCINOMA - AN IMPORTANT NEW INDEPENDENT INDICATOR OF PROGNOSIS [J].
BARNES, DM ;
DUBLIN, EA ;
FISHER, CJ ;
LEVISON, DA ;
MILLIS, RR .
HUMAN PATHOLOGY, 1993, 24 (05) :469-476
[4]  
JOTTI GS, 1994, J CLIN PATHOL, V47, P900
[5]  
KINSEL LB, 1989, CANCER RES, V49, P1052
[6]  
MCCLELLAND RA, 1990, CANCER RES, V50, P3545
[7]  
Osborne CK, 1991, BREAST DISEASES, P301